Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Graphite Purification Tolling Services December 16, 2025 Rare Earths Oxide Produced from Halleck Creek Ore-Major Technical Breakthrough December 16, 2025 LaFleur Minerals Announces LIFE and Flow-Through Unit Offerings December 16, 2025